F M Investments LLC lifted its holdings in shares of MetLife, Inc. (NYSE:MET - Free Report) by 14.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 112,347 shares of the financial services provider's stock after purchasing an additional 13,929 shares during the quarter. F M Investments LLC's holdings in MetLife were worth $9,199,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also modified their holdings of the business. Geode Capital Management LLC lifted its position in shares of MetLife by 1.3% in the fourth quarter. Geode Capital Management LLC now owns 11,931,536 shares of the financial services provider's stock worth $973,901,000 after buying an additional 158,107 shares during the last quarter. Norges Bank acquired a new position in MetLife during the fourth quarter valued at approximately $730,716,000. Bank of New York Mellon Corp lifted its stake in shares of MetLife by 109.2% in the fourth quarter. Bank of New York Mellon Corp now owns 8,826,658 shares of the financial services provider's stock worth $722,727,000 after buying an additional 4,606,748 shares during the last quarter. Clearbridge Investments LLC boosted its holdings in shares of MetLife by 43.7% during the 4th quarter. Clearbridge Investments LLC now owns 5,663,177 shares of the financial services provider's stock worth $463,701,000 after buying an additional 1,723,461 shares during the period. Finally, Nordea Investment Management AB grew its position in shares of MetLife by 16.8% in the fourth quarter. Nordea Investment Management AB now owns 4,238,087 shares of the financial services provider's stock valued at $347,735,000 after purchasing an additional 608,224 shares during the last quarter. Institutional investors and hedge funds own 94.99% of the company's stock.
Wall Street Analysts Forecast Growth
Several research firms recently commented on MET. Keefe, Bruyette & Woods cut their target price on shares of MetLife from $98.00 to $95.00 and set an "outperform" rating for the company in a research note on Wednesday, April 9th. Morgan Stanley dropped their price objective on shares of MetLife from $109.00 to $94.00 and set an "overweight" rating for the company in a report on Thursday, April 10th. UBS Group boosted their price objective on shares of MetLife from $94.00 to $98.00 and gave the stock a "buy" rating in a research report on Wednesday, April 2nd. Wells Fargo & Company cut their price objective on shares of MetLife from $97.00 to $91.00 and set an "overweight" rating on the stock in a report on Thursday, April 10th. Finally, Barclays decreased their target price on MetLife from $95.00 to $88.00 and set an "overweight" rating for the company in a research report on Friday. Two analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat, MetLife currently has an average rating of "Moderate Buy" and a consensus target price of $92.46.
Check Out Our Latest Analysis on MET
MetLife Stock Up 0.4 %
Shares of MetLife stock traded up $0.27 during trading hours on Tuesday, reaching $73.22. 705,637 shares of the company's stock were exchanged, compared to its average volume of 3,391,510. MetLife, Inc. has a fifty-two week low of $65.21 and a fifty-two week high of $89.05. The stock has a market cap of $49.88 billion, a P/E ratio of 12.26, a P/E/G ratio of 0.65 and a beta of 0.89. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.54. The company has a 50 day moving average of $80.08 and a two-hundred day moving average of $82.40.
MetLife (NYSE:MET - Get Free Report) last posted its earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share for the quarter, missing analysts' consensus estimates of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. On average, sell-side analysts forecast that MetLife, Inc. will post 9.65 EPS for the current fiscal year.
MetLife Profile
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Read More

Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.